Angiotensin II regulates activation of Bim via Rb/E2F1 during apoptosis: Involvement of interaction between AMPKβ/2 and Cdk4

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 303, Issue 3, 2012, Pages

  Kim, Yong Chul ^a   Day, Regina M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Akt; AT 2 receptor; Fibrosis; Lung endothelial cells

Indexed keywords

ANGIOTENSIN II; BIM PROTEIN; CYCLIN DEPENDENT KINASE 4; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE BETA 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE BETA 2; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PULMONARY ARTERY ENDOTHELIAL CELL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

AMP-ACTIVATED PROTEIN KINASES; ANGIOTENSIN II; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOTTING, WESTERN; CATTLE; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE 4; E2F1 TRANSCRIPTION FACTOR; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; MEMBRANE PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS; PULMONARY ARTERY; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION;

EID: 84864756334     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00087.2012     Document Type: Article

References (63)

1. Aranovich A, Liu Q, Collins T, Geng F, Dixit S, Leber B, Andrews DW. Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells. Mol Cell 45: 754-763, 2012.
2. Bell LA, O'Prey J, Ryan KM. DNA-binding independent cell death from a minimal proapoptotic region of E2F-1. Oncogene 25: 5656-5663, 2006.
3. Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med 2: 247-257, 2010.
4. Biswas SC, Liu DX, Greene LA. Bim is a direct target of a neuronal E2F-dependent apoptotic pathway. J Neurosci 25: 8349-8358, 2005.
5. Blain SW. Switching cyclin D-Cdk4 kinase activity on and off. Cell Cycle 7: 892-898, 2008.
6. Bouillet P, Zhang LC, Huang DC, Webb GC, Bottema CD, Shore P, Eyre HJ, Sutherland GR, Adams JM. Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim. Mamm Genome 12: 163-168, 2001.
7. Concannon CG, Tuffy LP, Weisova P, Bonner HP, Davila D, Bonner C, Devocelle MC, Strasser A, Ward MW, Prehn JH. AMP kinase- mediated activation of the BH3-only protein Bim couples energy depletion to stress-induced apoptosis. J Cell Biol 189: 83-94, 2010.
8. Dasgupta B, Milbrandt J. AMP-activated protein kinase phosphorylates retinoblastoma protein to control mammalian brain development. Dev Cell 16: 256-270, 2009.
9. Dasgupta P, Padmanabhan J, Chellappan S. Rb function in the apo-ptosis and senescence of non-neuronal and neuronal cells: role in onco-genesis. Curr Mol Med 6: 719-729, 2006.
10. Day RM, Lee YH, Han L, Kim YC, Feng YH. Angiotensin II activates AMPK for execution of apoptosis through energy-dependent and -independent mechanisms. Am J Physiol Lung Cell Mol Physiol 301: L772- L781, 2011.
11. Dewson G, Kluck RM. Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis. J Cell Sci 122: 2801-2808, 2009.
12. Dijkers PF, Medema RH, Lammers JW, Koenderman L, Coffer PJ. Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1. Curr Biol 10: 1201-1204, 2000.
13. Garrison SP, Phillips DC, Jeffers JR, Chipuk JE, Parsons MJ, Rehg JE, Opferman JT, Green DR, Zambetti GP. Genetically defining the mechanism of Puma- and Bim-induced apoptosis. Cell Death Differ 19: 642-649, 2012.
14. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE, Shaw RJ. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30: 214-226, 2008.
15. Halaban R, Cheng E, Zhang Y, Mandigo CE, Miglarese MR. Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1. Onco-gene 16: 2489-2501, 1998.
16. Hallstrom TC, Mori S, Nevins JR. An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 13: 11-22, 2008.
17. Hallstrom TC, Nevins JR. Balancing the decision of cell proliferation and cell fate. Cell Cycle 8: 532-535, 2009.
18. Hao H, Dong Y, Bowling MT, Gomez-Gutierrez JG, Zhou HS, Mc-Masters KM. E2F-1 induces melanoma cell apoptosis via PUMA up-regulation and Bax translocation. BMC Cancer 7: 24, 2007.
19. Harbour JW, Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 14: 2393-2409, 2000.
20. Hardie DG. AMP-activated protein kinase-an energy sensor that regulates all aspects of cell function. Genes Dev 25: 1895-1908, 2011.
21. Hershko T, Ginsberg D. Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. J Biol Chem 279: 8627- 8634, 2004.
22. Horiuchi M, Hayashida W, Kambe T, Yamada T, Dzau VJ. Angio-tensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen-activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem 272: 19022-19026, 1997.
23. Iaquinta PJ, Lees JA. Life and death decisions by the E2F transcription factors. Curr Opin Cell Biol 19: 649-657, 2007.
24. Ino H, Chiba T. Cyclin-dependent kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo. J Neurosci 21: 6086- 6094, 2001.
25. Jiao W, Lin HM, Timmons J, Nagaich AK, Ng SW, Misteli T, Rane SG. E2F-dependent repression of topoisomerase II regulates heterochro-matin formation and apoptosis in cells with melanoma-prone mutation. Cancer Res 65: 4067-4077, 2005.
26. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 7: 331-342, 1993.
27. Kim YC, Gerlitz G, Furusawa T, Catez F, Nussenzweig A, Oh KS, Kraemer KH, Shiloh Y, Bustin M. Activation of ATM depends on chromatin interactions occurring before induction of DNA damage. Nat Cell Biol 11: 92-96, 2009.
28. Kim YC, Kim SY, Mellado-Gil JM, Yadav H, Neidermyer W, Kama-raju AK, Rane SG. RB regulates pancreas development by stabilizing Pdx1. EMBO J 30: 1563-1576, 2011.
29. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275: 1132-1136, 1997.
30. Konigshoff M, Wilhelm A, Jahn A, Sedding D, Amarie OV, Eul B, Seeger W, Fink L, Gunther A, Eickelberg O, Rose F. The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis. Am J Respir Cell Mol Biol 37: 640-650, 2007.
31. Lambert DW, Clarke NE, Turner AJ. Not just angiotensinases: new roles for the angiotensin-converting enzymes. Cell Mol Life Sci 67: 89-98, 2010.
32. Lee CW, Sorensen TS, Shikama N, La Thangue N.B. Functional interplay between p53 and E2F through co-activator p300. Oncogene 16: 2695-2710, 1998.
33. Lee YH, Mungunsukh O, Tutino RL, Marquez AP, Day RM. Angio-tensin II-induced apoptosis requires SHP-2 regulation of nucleolin and Bcl-xL in primary lung endothelial cells. J Cell Sci 123: 1634-1643, 2010.
34. Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Kors-meyer SJ. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2: 183-192, 2002.
35. Li WQ, Guszczynski T, Hixon JA, Durum SK. Interleukin-7 regulates Bim proapoptotic activity in peripheral T-cell survival. Mol Cell Biol 30: 590-600.
36. Liu K, Paik JC, Wang B, Lin FT, Lin WC. Regulation of TopBP1 oligomerization by Akt/PKB for cell survival. EMBO J 25: 4795-4807, 2006.
37. Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 13: 1016-1023, 2011.
38. Mogi M, Iwai M, Horiuchi M. Emerging concepts of regulation of angiotensin II receptors: new players and targets for traditional receptors. Arterioscler Thromb Vasc Biol 27: 2532-2539, 2007.
39. Padmanabhan J, Park DS, Greene LA, Shelanski ML. Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis. J Neu-rosci 19: 8747-8756, 1999.
40. Pan Z, Wang J, Yin X, Xie P, Yang J, Jiang J, Zhang L, He F. The function study on the interaction between Grb2 and AMPK. Mol Cell Biochem 307: 121-127, 2008.
41. Papp M, Li X, Zhuang J, Wang R, Uhal BD. Angiotensin receptor inftype AT(1) mediates alveolar epithelial cell apoptosis in response to ANG II. Am J Physiol Lung Cell Mol Physiol 282: L713-L718, 2002.
42. Park SY, Jeong MS, Jang SB. In vitro binding properties of tumor suppressor p53 with PUMA and NOXA. Biochem Biophys Res Commun 420: 350-356, 2012.
43. Pediconi N, Ianari A, Costanzo A, Belloni L, Gallo R, Cimino L, Porcellini A, Screpanti I, Balsano C, Alesse E, Gulino A, Levrero M. Differential regulation of E2F1 apoptotic target genes in response to DNA damage. Nat Cell Biol 5: 552-558, 2003.
44. Porrello ER, Delbridge LM, Thomas WG. The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor. Front Biosci 14: 958-972, 2009.
45. Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet 22: 44-52, 1999.
46. Rao HV, Thirumangalakudi L, Desmond P, Grammas P. Cyclin D1, cdk4, and Bim are involved in thrombin-induced apoptosis in cultured cortical neurons. J Neurochem 101: 498-505, 2007.
47. Richter EA, Ruderman NB. AMPK and the biochemistry of exercise: implications for human health and disease. Biochem J 418: 261-275, 2009.
48. Rossig L, Hermann C, Haendeler J, Assmus B, Zeiher AM, Dimmeler S. Angiotensin II-induced upregulation of MAP kinase phosphatase-3 mRNA levels mediates endothelial cell apotosis. Basic Res Cardiol 97: 1-8, 2002.
49. Ruiz-Ortega M, Ruperez M, Esteban V, Rodriguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J. Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases. Nephrol Dial Transplant 21: 16-20, 2006.
50. She QB, Solit DB, Ye Q, O'Reilly KE, Lobo J, Rosen N. The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells. Cancer Cell 8: 287-297, 2005.
51. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95: 651-657, 1995.
52. Sugimoto M, Yamaoka Y, Shirai N, Furuta T. The role of the renin-angiotensin system in gastric oncogenesis. J Gastroenterol Hepatol 27: 442-451, 2011.
53. Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res 100: 328-341, 2007.
54. Uhal BD. Apoptosis in lung fibrosis and repair. Chest 122: 293S-298S, 2002.
55. van den Heuvel S, Dyson NJ. Conserved functions of the pRB and E2F families. Nat Rev Mol Cell Biol 9: 713-724, 2008.
56. Vandel L, Nicolas E, Vaute O, Ferreira R, Ait-Si-Ali S, Trouche D. Transcriptional repression by the retinoblastoma protein through the recruitment of a histone methyltransferase. Mol Cell Biol 21: 6484-6494, 2001.
57. Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausser-lechner MJ, Adams JM, Strasser A. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302: 1036-1038, 2003.
58. Vogler M. BCL2A1: the underdog in the BCL2 family. Cell Death Differ 19: 67-74, 2012.
59. Wallace M, Ball KL. Docking-dependent regulation of the Rb tumor suppressor protein by Cdk4. Mol Cell Biol 24: 5606-5619, 2004.
60. Wang C, Rauscher FJ 3rd, Cress WD, Chen J. Regulation of E2F1 function by the nuclear corepressor KAP1. J Biol Chem 282: 29902- 29909, 2007.
61. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, Korsmeyer SJ. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730, 2001.
62. Wong KA, Lodish HF. A revised model for AMP-activated protein kinase structure: the alpha-infunit binds to both the beta- and gamma-infunits although there is no direct binding between the beta- and gamma-infunits. J Biol Chem 281: 36434-36442, 2006.
63. Wu ZL, Zheng SS, Li ZM, Qiao YY, Aau MY, Yu Q. Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression. Cell Death Differ 17: 801-810, 2010.